PDCD1 and neoplasm: Chitin-mediated CLP blockade significantly reduces immunosuppressive cell types and stimulates anti-PD-1 efficacy with concomitant decrease in disease progression and increase in anti-tumorigenic lymphocytes both in the primary tumor and lymphoid organs.